Document Detail

The optimal treatment of STEMI: new pharmacological and device approaches.
MedLine Citation:
PMID:  24434342     Owner:  NLM     Status:  In-Data-Review    
Cardiovascular disease remains the leading cause of mortality worldwide. Many deaths are contributed to acute ST elevation myocardial infarction (STEMI). Recently, epidemiological studies have been shown reduction in STEMI related mortality over the last decade. This reduction has partially been attributed to new pharmacological and device advances that were utilized during STEMI treatment. The goal of this manuscript is to review new pharmacological and device approaches available in the treatment of STEMI patients.
M R Movahed
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Panminerva medica     Volume:  55     ISSN:  1827-1898     ISO Abbreviation:  Panminerva Med     Publication Date:  2013 Dec 
Date Detail:
Created Date:  2014-01-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0421110     Medline TA:  Panminerva Med     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  339-43     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Current state of percutaneous transcatheter mitral valve therapies.
Next Document:  Innovations in drug-eluting stents.